News

IBM Watson for Oncology and Cota Combined in Pilot Study To Guide Clinical Decisions

IBM’s Watson for Oncology, which interprets patient data and provides treatment guidance, and Cota, which provides real-world patient data for large cohort analysis and individualized treatment guidance, will be combined in a pilot study with Hackensack Meridian Health to help oncologists make improved evidence- and outcomes-based clinical decisions for their cancer patients and potentially also reduce overall costs of care.

Read full article on targetedonc.com.